Launch week offerEnds in00h00m00s

annual Promonthly Pro

Rabah Serya

Professor and head of Pharmaceutical Chemistry Dep

Ain Shams University

Egypt

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Biochemistry

Articles (12)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Sama Wael

Lecturer

Ain Shams University

EGYPT

View details

F. G. West

University of Alberta

CANADA

View details

Amal Kamal Abdel-Aziz

Associate Professor of Pharmacology and Toxicology

European Institute of Oncology

EGYPT

View details

Sameh Saad Ali

Head of Tumor Biology Program

Children's Cancer Hospital Egypt 57357

EGYPT

View details

Khaled Abouzid

Professor

Ain Shams University

EGYPT

View details

Martin McPhillie

Lecturer

University of Leeds

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rabah Serya

Research Interests

Make your next move.

Explore related searches

Articles (12)

Design, synthesis, in silico, and biological evaluation of novel pyrazolopyrimidinone-based estrogen receptor inhibitors

Ligand-Based Design of Novel Thiazole-Quinazolinone Hybrids with Dual Antimicrobial and Anti-Virulence Activity Targeting Staphylococcal Sortase A

Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML

Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds

Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents

Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors

Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy

Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells

Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors

AML and FLT3: An Update on FDA-approved or Under Review Kinase Inhibitors Targeting FLT3 Kinase

A Fluorescence-Based Assay to Probe Inhibitory Effect of Fructose Mimics on GLUT5 Transport in Breast Cancer Cells

Hit Identification Against Candida Albicans: Design, Synthesis, Molecular Docking and Biological Evaluation of Hybrid Styryl-Quinoxaline Based Analogues

Collaborators (6)

Sama Wael

F. G. West

Amal Kamal Abdel-Aziz

Sameh Saad Ali

Khaled Abouzid

Martin McPhillie

Make your next move.